| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018640 |
| Receipt No. | R000021567 |
| Official scientific title of the study | The effect of Stand/Gait rehabilitation using BCAA and vitamin D high formulated nutritional supplement from the acute phase for inpatients with gait disturbance, Randomized, Open-Label, Comparative Study |
| Date of disclosure of the study information | 2015/08/11 |
| Last modified on | 2016/09/28 (Ver. 10) |
| Basic information | ||
| Official scientific title of the study | The effect of Stand/Gait rehabilitation using BCAA and vitamin D high formulated nutritional supplement from the acute phase for inpatients with gait disturbance, Randomized, Open-Label, Comparative Study | |
| Title of the study (Brief title) | The effect of Stand/Gait rehabilitation using BCAA and vitamin D high formulated nutritional supplement | |
| Region |
|
|
| Condition | |||
| Condition | Hospitalized patient with gait disturbance | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the effects of Stand/Gait Training using BCAA and vitamin D high formulated nutritional supplement from the acute phase for inpatients with gait disturbance on ADL, physical activity, skeletal muscle mass and muscle strength. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Motor FIM gain
Assessment in baseline and every month |
| Key secondary outcomes | 1.Muscle mass (measured by the InBody S10 every 2 weeks)
2.Muscle strength (mesured by the dynamometer) 3.Swallowing function (FILS, tongue pressure) 4.Cognitive function(HDS-R, FIM) 5.Nutritional assessment(MNA-SF, BMI, Alb, Lymphocyte Count) 6.Gait function (Timed up & go test, 6 minutes-walk test , gait speed ) 2-6:Assessment in baseline and every month |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Stand/Gait training with BCAA and vitamin D high formulated nutritional supplement
1.Jelly type nutritional supplement 2 bags per day BCAA 2500 mg, vit.D 800iu per one bag of the nutritional supplement It starts within two weeks from hospitalization It continues until discharge 2.Stand/Gait training with therapist |
|
| Interventions/Control_2 | Stand/Gait training without BCAA and vitamin D high formulated nutritional supplement
1.Stand/Gait training with therapist |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.FIM score of locomotion is less than 5 or 6 whose gait speed is less than 0.8m/s
2.Stand/Gait training in physical therapy 3.Able to intervene in continuously from the acute phase ward to the recovery phase rehabilitation ward 4.Patient with more than 70% of dietary intake 5.Agreement to participate in the research. |
|||
| Key exclusion criteria | 1.Cow's milk allergy, soybean allergy, citrus fruit allergy
2.Severe renal dysfunction (GFR<30) 3.Patients who cannot take in jelly at all |
|||
| Target sample size | 78 | |||
| Research contact person | |
| Name of lead principal investigator | Misa Moriwaki |
| Organization | Midorigaoka Hospital |
| Division name | Department of Rehabilitation, medical office |
| Address | 3-13-1Makami-cho,Takatsuki-city,Osaka prefecture |
| TEL | 027-681-5975 |
| reha-1@midorigaoka.or.jp | |
| Public contact | |
| Name of contact person | Misa Moriwaki |
| Organization | Midorigaoka Hospital |
| Division name | Department of Rehabilitation, medical office |
| Address | 3-13-1Makami-cho,Takatsuki-city,Osaka prefecture |
| TEL | 027-681-5975 |
| Homepage URL | |
| reha-1@midorigaoka.or.jp | |
| Sponsor | |
| Institute | Midorigaoka Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 社会医療法人祐生会 みどりヶ丘病院(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021567 |